Reference no: EM133421636
Assignment:
Research a guide for the treatment of depressive disorders in a vulnerable population for older adults Be sure to use language appropriate for your audience (patient, caregiver, parent, etc.). Include non-copyright images and/or information tables to make your patient medication guide interesting and appealing.
- Depressive disorder causes and symptoms
- How depression is diagnosed for the vulnerable population of your choice, why is this population considered vulnerable
- Medication treatment options including risk vs benefits; side effects; FDA approvals for the vulnerable population of your choice
- Medication considerations of medication examples prescribed (see last bullet item)
- What is important to monitor in terms of labs, comorbid medical issues with why important for monitoring
- Special Considerations (you must be specific, not general, and address at least one for EACH category; you must demonstrate critical thinking beyond basics of HIPPA and informed consent!): legal considerations, ethical considerations, cultural considerations, social determinants of health
- Where to follow up in your local community for further information
- Provide 3 examples of a proper prescription that you would provide to the patient or transmit to the pharmacy. Use 3 outside resources from your school resources
References
Baek, J. H., Nierenberg, A. A., & Fava, M. (2016). Pharmacological approaches to treatment-resistant depression. In T. A. Stern, M. Favo, T. E. Wilens, & J. F. Rosenbaum. (Eds.), Massachusetts General Hospital psychopharmacology and neurotherapeutics (pp. 44-47). Elsevier.
Fava, M., & Papakostas, G. I. (2016). Antidepressants. In T. A. Stern, M. Favo, T. E. Wilens, & J. F. Rosenbaum. (Eds.), Massachusetts General Hospital psychopharmacology and neurotherapeutics (pp. 27-43). Elsevier.
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.)
Howland, R. H. (2008a). Sequenced Treatment Alternatives to Relieve Depression (STAR*D). Part 1: Study design. Journal of Psychosocial Nursing and Mental Health Services.
Howland, R. H. (2008b). Sequenced Treatment Alternatives to Relieve Depression (STAR*D). Part 2: Study outcomes. Journal of Psychosocial Nursing and Mental Health Services.
Lorberg, B., Davico, C., Martsenkovskyi, D., & Vitiello, B. (2019). Principles in using psychotropic medication in children and adolescents. In J. M. Rey & A. Martin (Eds.), IACAPAP e-textbook of child and adolescent mental health.
Magellan Health. (2013). Appropriate use of psychotropic drugs in children and adolescents: A clinical monograph.
Poznanski, E. O., & Mokros, H. B. (1996). Child depression rating scale-Revised. Western Psychological Services. Rao, U. (2013). Biomarkers in pediatric depression. Depression & Anxiety.
Yasuda, S. U., Zhang, L. & Huang, S.-M. (2008). The role of ethnicity in variability in response to drugs: Focus on clinical pharmacology studies. Clinical Pharmacology & Therapeutics.
Please include other resources that are used so I may do further research also can citations be added so I'll know where the information came from.